HAE Update: Special considerations in the female patient with hereditary angioedema

Allergy and Asthma Proceedings

Volumn 34, Issue 1, 2013, Pages 13-18

  Geng, Bob ^a   Riedl, Marc A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BLOOD CLOTTING FACTOR 12; BRADYKININ B2 RECEPTOR; COMPLEMENT COMPONENT C1S INHIBITOR; ECALLANTIDE; ESTROGEN; FRESH FROZEN PLASMA; ICATIBANT; PROGESTERONE;

ANDROGEN THERAPY; ANGIONEUROTIC EDEMA; CHILDBIRTH; CONFERENCE PAPER; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DRUG SAFETY; ESTROGEN BLOOD LEVEL; FEMALE; FETUS CIRCULATION; FIRST TRIMESTER PREGNANCY; GENE MUTATION; GENITAL EDEMA; HIRSUTISM; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; INSTRUMENTAL DELIVERY; LABOR; MENSTRUATION DISORDER; ORAL CONTRACEPTION; PHENOTYPE; PLACENTA CIRCULATION; PREGNANCY; PROGESTERONE BLOOD LEVEL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; VAGINAL DELIVERY; VIRILIZATION; VOICE CHANGE; WEIGHT GAIN;

BRADYKININ; CONTRACEPTIVE AGENTS; ESTROGENS; FACTOR XII; FEMALE; HEREDITARY ANGIOEDEMA TYPE III; HORMONE REPLACEMENT THERAPY; HUMANS; MUTATION; PEPTIDES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84874343514     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3635     Document Type: Conference Paper

References (30)

1. Caballero T, Farkas H, Bouillet L, et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 129:308-320, 2012.
2. Bork K, Wulff K, Hardt J, et al. Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapy. J Allergy Clin Immunol 124:129-134.
3. Zilberberg MD, Nathanson BH, Jacobsen T, and Tillotson G. Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006-2007. Allergy Asthma Proc 32:390-394, 2011.
4. Zilberberg MD, Nathanson BH, Jacobsen T, and Tillotson G. Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007. Allergy Asthma Proc 32:248-254, 2011.
5. Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 6:15, 2010.
6. Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 199:484.e1-4, 2008.
7. Bork K, Fischer B, and Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 114:294-298, 2003. (Pubitemid 36398075)
8. Chen LM, Chung P, Chao S, et al. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim Biophys Acta 1131:145-151, 1992.
9. Madeddu P, Emanueli C, Song Q, et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol 121: 1763-1769, 1997. (Pubitemid 27343408)
10. Hoem NO, Johannesen S, Hauge G, et al. Contact activation factors in plasma from women using oral contraceptives increased levels of factor XII, kin-free high molecular weight kininogen and acetone-activated kallikrein. Thromb Res 64:427-434, 1991.
11. Czaller I, Visy B, Csuka D, et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: A long-term survey. Eur J Obstet Gynecol Reprod Bio 152:44-49, 2010.
12. Cohen AJ, Laskin C, and Tarlo S. C1 esterase inhibitor in pregnancy. J Allergy Clin Immunol 90:412-413, 1992.
13. Chinniah N, and Katelaris CH. Hereditary angioedema and pregnancy. Aust N Z J Obstet Gynaecol 49:2-5, 2009.
14. Riedl MA. Update on the acute treatment of hereditary angioedema. Allergy Asthma Proc 32:11-16, 2011.
15. Frank MM. Update on preventive therapy (prophylaxis) of hereditary angioedema. Allergy Asthma Proc 32:17-21, 2011.
16. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6:24, 2010.
17. Sheffer AL, Austen KF, and Rosen FS. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med 287:452-454, 1972.
18. Frank MM, Sergent JS, Kane MA, and Alling DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 286:808-812, 1972.
19. Cicardi M, Castelli R, Zingale LC, and Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients. J Allergy Clin Immunol 99:194-196, 1997. (Pubitemid 27091567)
20. Brown J, Farquhar C, Lee O, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 15:CD000194, 2009.
21. Dunn CJ, and Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 57:1005-1032, 1999. (Pubitemid 29313210)
22. Reschini E, Giustina G, D'Alberton A, and Candiani BG. Female pseudohermaphroditism due to maternal androgen administration: 25-Year follow-up. Lancet 1:1226, 1985. (Pubitemid 15083698)
23. Martin L, Raison-Peyron N, Numlatothen MM, et al. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol 120:975-977, 2007. (Pubitemid 47531849)
24. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 26:709-724, 2006. (Pubitemid 44666307)
25. Bork K, Gumlatul D, Hardt J, and Dewald G. Hereditary angioedema with normal C1 inhibitor: Clinical symptoms and course. Am J Med 120:987-992, 2007. (Pubitemid 47633496)
26. Bork K, Wulff K, Meinke P, et al. A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol 141:31-35, 2011.
27. Dewald G and Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343: 1286-1289, 2006.
28. Bork K. Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex. Am J Med 116:644-645, 2004. (Pubitemid 38490542)
29. Bouillet L, Boccon-Gibod I, Ponard D, et al. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. Ann Allergy Asthma Immunol 103:448-448, 2009.
30. Cronin JA, and Maples KM. Treatment of an acute attack of type III hereditary angioedema with ecallantide. Ann Allergy Asthma Immunol 108:61-62, 2012.